Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review - H1 2014





Published: May 2014 | Pages: 71 | Format: PDF

 Summary 

 GlobalData's clinical trial report, “Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2014" provides data on the Addison’s Disease (Primary or Chronic Adrenal Insufficiency) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Addison’s Disease (Primary or Chronic Adrenal Insufficiency). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Addison’s Disease (Primary or Chronic Adrenal Insufficiency). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

 Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. 

 Scope 

 

  •  Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations  
  •  Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type 
  •  Listings of discontinued trials (suspended, withdrawn and terminated) 

 

 Reasons to buy 

 

  •  Understand the dynamics of a particular indication in a condensed manner 
  •  Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more 
  •  Obtain discontinued trial listing for trials across the globe 
  •  Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies 

 

 Table of Contents 

 Introduction 6 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) 6 

 Report Guidance 6 

 Clinical Trials by Region 7 

 Clinical Trials and Average Enrollment by Country 8 

 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 

 Top Five Countries Contributing to Clinical Trials in Europe 11 

 Top Countries Contributing to Clinical Trials in North America 12 

 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 

 Clinical Trials by G7 Countries: Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials 14 

 Clinical Trials by Phase in G7 Countries 15 

 Clinical Trials in G7 Countries by Trial Status 16 

 Clinical Trials by E7 Countries: Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials 17 

 Clinical Trials in E7 Countries by Trial Status 18 

 Clinical Trials by Phase 19 

 In Progress Trials by Phase 20 

 Clinical Trials by Trial Status 21 

 Clinical Trials by End Point Status 22 

 Unaccomplished Trials of Addison's Disease (Primary or Chronic Adrenal Insufficiency) 23 

 Subjects Recruited Over a Period of Time 24 

 Clinical Trials by Sponsor Type 25 

 Prominent Sponsors 26 

 Top Companies Participating in Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials 27 

 Prominent Drugs 28 

 Clinical Trial Profiles 29 

 Clinical Trial Overview of Top Companies 29 

 Shire Plc 29 

 Clinical Trial Overview of Shire Plc 29 

 DuoCort AB 30 

 Clinical Trial Overview of DuoCort AB 30 

 Clinical Trial Overview of Top Institutes / Government 31 

 Haukeland University Hospital 31 

 Clinical Trial Overview of Haukeland University Hospital 31 

 UMC Utrecht Holding BV 32 

 Clinical Trial Overview of UMC Utrecht Holding BV 32 

 University of Wurzburg 33 

 Clinical Trial Overview of University of Wurzburg 33 

 HaEmek Medical Center 34 

 Clinical Trial Overview of HaEmek Medical Center 34 

 Aarhus University 35 

 Clinical Trial Overview of Aarhus University 35 

 Newcastle University 36 

 Clinical Trial Overview of Newcastle University 36 

 University Hospital Tubingen 37 

 Clinical Trial Overview of University Hospital Tubingen 37 

 Nantes University Hospital 38 

 Clinical Trial Overview of Nantes University Hospital 38 

 Oregon Health and Science University 39 

 Clinical Trial Overview of Oregon Health and Science University 39 

 Rigshospitalet 40 

 Clinical Trial Overview of Rigshospitalet 40 

 Five Key Clinical Profiles 41 

 Appendix 69 

 Abbreviations 69 

 Definitions 69 

 Research Methodology 70 

 Secondary Research 70 

 About GlobalData 71 

 Contact Us 71 

 Disclaimer 71 

 Source 71 

  

 List of Tables 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region, 2014* 7 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13 

 Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16 

 Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase, 2014* 19 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Terminated Clinical Trials, 2014* 23 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014* 29 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by DuoCort AB, 2014* 30 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2014* 31 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 32 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wurzburg, 2014* 33 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014* 34 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 35 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Newcastle University, 2014* 36 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2014* 37 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2014* 38 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 39 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 40 

  

 List of Figures 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 

 Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16 

 Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27 

 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28 

 GlobalData Methodology 70